Behavioural problems and personality change related to cerebral amyloid angiopathy;Verhaltensauffälligkeiten und Persönlichkeitsveränderung bei zerebraler Amyloidangiopathie

Psychiatrische Praxis

Volumn 39, Issue 8, 2012, Pages 410-413

  Gahr, Maximilian ^a   Connemann, Bernhardj ^a   Schönfeldt Lecuona, Carlos ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

amyloidosis; behavioural disturbances; mental disorder due to a medical condition; mild cognitive impairment; organic personality disorder

Indexed keywords

ARTICLE; BEHAVIOR DISORDER; PERSONALITY; VASCULAR AMYLOIDOSIS;

CAREGIVERS; COMBINED MODALITY THERAPY; COOPERATIVE BEHAVIOR; CRISIS INTERVENTION; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; DEMENTIA, VASCULAR; DEPRESSIVE DISORDER; DISEASE PROGRESSION; FAMILY CONFLICT; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERDISCIPLINARY COMMUNICATION; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PATIENT ADMISSION; PATIENT READMISSION; PERSONALITY DISORDERS; PSYCHOTROPIC DRUGS; SOCIAL BEHAVIOR DISORDERS; SUICIDE, ATTEMPTED;

EID: 84869087246     PISSN: 03034259     EISSN: 14390876     Source Type: Journal    
DOI: 10.1055/s-0032-1305119     Document Type: Article

References (15)

1. Biffi A., Greenberg S. Cerebral amyloid angiopathy: a systematic review. J Clin Neurol: 2011; 7 1 9
2. Merlini G., Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med: 2003; 349 583 596 (Pubitemid 36951371)
3. Perfetto F., Moggi-Pignone A., Livi R. et al. Systemic amyloidosis: a challenge for the rheumatologist. Nat Rev Rheumatol: 2010; 6 417 429
4. Pezzini A., Del Zotto E., Volonghi I. et al. Cerebral amyloid angiopathy: a common cause of cerebral hemorrhage. Curr Med Chem: 2009; 16 2498 2513
5. Viswanathan A., Greenberg S. Cerebral amyloid angiopathy in the elderly. Ann Neurol: 2011; 70 871 880
6. Cooper J. ICD-10 Classification of Mental and Behavioural Disorders with Glossary and Diagnostic Criteria for Research ICD-10: DCR-10. Edinburgh, London, Melbourne, New York, Tokyo WHO: 1994
7. Knudson K., Rosand J., Karluk D. et al. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston citeria. Neurology: 2001; 56 537 539 (Pubitemid 32172884)
8. de Jong D., Kremer B., Olde Rikkert M. et al. Current state and future directions of neurochemical biomarkers for Alzheimer's disease. Clin Chem Lab Med: 2007; 45 1421 1434 (Pubitemid 350036575)
9. Verbeek M., Kremer B., Rikkert M. et al. Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy. Ann Neurol: 2009; 66 245 249
10. Attems J., Jellinger K., Thal J. et al. Review: Sporadic cerebral amyloid angiopathy. Neuropathol Appl Neurobiol: 2011; 37 75 93
11. Charidimou A., Gang Q., Werring D. Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiat: 2012; 83 124 137
12. Greenberg S., Vonsattel J., Stakes J. et al. The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology: 1993; 43 2073 2079 (Pubitemid 23318883)
13. Greenberg S., Gurol M., Rosand J. et al. Amyloid angiopathy-related vascular cognitive impairment. Stroke: 2004; 35 01 2616 2619 (Pubitemid 39458351)
14. Gorelick P., Scuteri A., Black S. et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke: 2011; 42 2672 2713
15. Smith E., Greenberg S. Beta-amyloid, blood vessels, and brain function. Stroke: 2009; 40 2601 2606